Publications

The first-in-human study of CNTO 7160, an anti-interleukin-33 receptor monoclonal antibody, in healthy subjects and patients with asthma or atopic dermatitis

Publié en January 2020 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
January 2020

Is CCL18 a potential biomarker of type-2 asthma?

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Previous publication
January 2020

How can we minimise the use of regular oral corticosteroids in asthma? (vol 29, 190085, 2020)

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Next publication

Authors